Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,128 public trials 394 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada

NCT05578417

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Alberta Health Services Calgary, Alberta, Canada
  • Alberta Health Services Edmonton, Alberta, Canada
  • Vancouver Allergy Clinic Vancouver, British Columbia, Canada
  • University of Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Completed

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

NCT02135419

Conditions
Acquired Immunodeficiency Syndrome, Anal Cancer, Anus Diseases, +38 more
Locations
  • UCLA CARE Clinic Los Angeles, California, United States
  • UCLA School of Nursing Los Angeles, California, United States
  • DAP Health Palm Springs, California, United States
  • University of California at San Francisco Anal Dysplasia Clinic San Francisco, California, United States
View all 25 locations
View Trial Details
Completed

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

NCT03500315

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 29 locations
View Trial Details
Completed

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

NCT02741128

Conditions
Acquired Immunodeficiency Syndrome, Arbovirus Infections, Blood-Borne Infections, +24 more
Locations
  • Investigational Site Number :0760002 Nova Iguaçu, Rio de Janeiro, Brazil
  • Investigational Site Number :0760004 Natal, Rio Grande do Norte, Brazil
  • Investigational Site Number :0760001 São Paulo, Brazil
  • Investigational Site Number :0760003 São Paulo, Brazil
View Trial Details

Related conditions